ALHC

SEC source: 0001628280-25-056788 · wk-form4_1765575146.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 2,346,726

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.84 to $19.46. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-25-055906 · wk-form4_1765236399.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 323,886

F1 · kind: Date of Rule 10b5-1 plan adoption: 09/08/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.16 to $19.62. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-054210 · wk-form4_1764201945.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,056,141

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/05/2025

SEC source: 0001628280-25-051755 · wk-form4_1762990214.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,081,141

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

SEC source: 0001628280-25-051753 · wk-form4_1762990083.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 2,526,726

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.01 to $16.54. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-25-046874 · wk-form4_1761691717.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,085,973

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/05/2025

SEC source: 0001222028-25-000008 · wk-form4_1760474379.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 2,706,726

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.97 to $17.60. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · balance_after: Balances in column 5 reflect the transfer on 09/25/2025 of 1,693,626 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

F4 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001993255-25-000011 · wk-form4_1760097561.xml · nonDerivative · entry 2

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 362,333

F2 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2025

SEC source: 0001993255-25-000011 · wk-form4_1760097561.xml · nonDerivative · entry 1

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 413,712

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

SEC source: 0000950142-25-002476 · es250680558_4-alhc1.xml · nonDerivative · entry 1

GENERAL ATLANTIC, L.P. · CIK 0001017645 · Director · 10% owner

GENERAL ATLANTIC GENPAR, L.P. · CIK 0001467926 · Director · 10% owner

General Atlantic Partners 95, L.P. · CIK 0001606259 · Director · 10% owner

GAP COINVESTMENTS III, LLC · CIK 0001282203 · Director · 10% owner

GAP COINVESTMENTS IV, LLC · CIK 0001282372 · Director · 10% owner

GAP Coinvestments V, LLC · CIK 0001793941 · Director · 10% owner

GAPCO GMBH & CO KG · CIK 0001187388 · Director · 10% owner

GAPCO MANAGEMENT GMBH · CIK 0001187390 · Director · 10% owner

GAP Coinvestments CDA, L.P. · CIK 0001356474 · Director · 10% owner

General Atlantic (SPV) GP, LLC · CIK 0001793940 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 24,596,079

F1 · kind: On September 17, 2025, General Atlantic (ALN HLTH), L.P., a Delaware limited partnership ("GA ALN"), completed its sale of 6,246,096 shares of Common Stock at a price per share of $16.01 in a private placement to a third party.

F2 · ownership.nature: Reflects (i) 24,287,227 shares of Common Stock held directly by GA ALN following the closing of the Transaction and (ii) 135,716 shares of Common Stock and 18,710 restricted stock units held by Nicholas Robbert Vorhoff and 135,716 shares of Common Stock and 18,710 restricted stock units held by David C. Hodgson, in each case for the benefit of General Atlantic Service Company, L.P. ("GASC"). The limited partners of GA ALN are the following investment funds (the "GA Funds"): General Atlantic Partners 95, L.P., a Delaware limited partnership ("GAP 95"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), GAP Coinvestments V, LLC, a Delaware limited liability company ("GAPCO V") and GAPCO GmbH & Co. KG, a German partnership ("GAPCO KG"). (Cont'd in FN3)

F3 · ownership.nature: (Cont'd from FN2) General Atlantic GenPar, L.P., a Delaware limited partnership ("GA GenPar"), is the general partner of GAP 95. General Atlantic (SPV) GP, LLC, a Delaware limited liability company ("GA SPV"), is the general partner of GA ALN. General Atlantic, L.P., a Delaware limited partnership ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. GA LP is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee"). GAPCO Management GmbH, a German company ("GAPCO Management"), is the general partner of GAPCO KG. The Partnership Committee also controls GASC as well as the investment and voting decisions of GAPCO Management. There are six members of the Partnership Committee. Each of the members of the Partnership Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein.

SEC source: 0000950142-25-002477 · es250680559_4-alhc2.xml · nonDerivative · entry 1

General Atlantic (ALN HLTH), L.P. · CIK 0001853603 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 24,596,079

F1 · kind: On September 17, 2025, General Atlantic (ALN HLTH), L.P., a Delaware limited partnership ("GA ALN"), completed its sale of 6,246,096 shares of Common Stock at a price per share of $16.01 in a private placement to a third party.

F2 · ownership.nature: Reflects (i) 24,287,227 shares of Common Stock held directly by GA ALN following the closing of the Transaction and (ii) 135,716 shares of Common Stock and 18,710 restricted stock units held by Nicholas Robbert Vorhoff and 135,716 shares of Common Stock and 18,710 restricted stock units held by David C. Hodgson, in each case for the benefit of General Atlantic Service Company, L.P. ("GASC"). The limited partners of GA ALN are the following investment funds (the "GA Funds"): General Atlantic Partners 95, L.P., a Delaware limited partnership ("GAP 95"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), GAP Coinvestments V, LLC, a Delaware limited liability company ("GAPCO V") and GAPCO GmbH & Co. KG, a German partnership ("GAPCO KG"). (Cont'd in FN3)

F3 · ownership.nature: (Cont'd from FN2) General Atlantic GenPar, L.P., a Delaware limited partnership ("GA GenPar"), is the general partner of GAP 95. General Atlantic (SPV) GP, LLC, a Delaware limited liability company ("GA SPV"), is the general partner of GA ALN. General Atlantic, L.P., a Delaware limited partnership ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. GA LP is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee"). GAPCO Management GmbH, a German company ("GAPCO Management"), is the general partner of GAPCO KG. The Partnership Committee also controls GASC as well as the investment and voting decisions of GAPCO Management. There are six members of the Partnership Committee. Each of the members of the Partnership Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein.

SEC source: 0001209523-25-000007 · wk-form4_1758139479.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,110,973

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

SEC source: 0000950142-25-002441 · es250679023_4-alhc1.xml · nonDerivative · entry 1

GENERAL ATLANTIC, L.P. · CIK 0001017645 · Director · 10% owner

GENERAL ATLANTIC GENPAR, L.P. · CIK 0001467926 · Director · 10% owner

General Atlantic Partners 95, L.P. · CIK 0001606259 · Director · 10% owner

GAP COINVESTMENTS III, LLC · CIK 0001282203 · Director · 10% owner

GAP COINVESTMENTS IV, LLC · CIK 0001282372 · Director · 10% owner

GAP Coinvestments V, LLC · CIK 0001793941 · Director · 10% owner

GAPCO GMBH & CO KG · CIK 0001187388 · Director · 10% owner

GAPCO MANAGEMENT GMBH · CIK 0001187390 · Director · 10% owner

GAP Coinvestments CDA, L.P. · CIK 0001356474 · Director · 10% owner

General Atlantic (SPV) GP, LLC · CIK 0001793940 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 30,842,175

F1 · kind: The shares of Common Stock were sold by General Atlantic (ALN HLTH), L.P., a Delaware limited partnership ("GA ALN"), pursuant to an open market sale of 13,460,000 shares of Common Stock settled on September 12, 2025 at a net price per share of $16.01.

F2 · ownership.nature: Reflects (i) 30,533,323 shares of Common Stock held directly by GA ALN following the closing of the Transaction and (ii) 135,716 shares of Common Stock and 18,710 restricted stock units held by Nicholas Robbert Vorhoff and 135,716 shares of Common Stock and 18,710 restricted stock units held by David C. Hodgson, in each case for the benefit of General Atlantic Service Company, L.P. ("GASC"). The limited partners of GA ALN are the following investment funds (the "GA Funds"): General Atlantic Partners 95, L.P., a Delaware limited partnership ("GAP 95"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), GAP Coinvestments V, LLC, a Delaware limited liability company ("GAPCO V") and GAPCO GmbH & Co. KG, a German partnership ("GAPCO KG"). (Cont'd in FN3)

F3 · ownership.nature: (Cont'd from FN2) General Atlantic GenPar, L.P., a Delaware limited partnership ("GA GenPar"), is the general partner of GAP 95. General Atlantic (SPV) GP, LLC, a Delaware limited liability company ("GA SPV"), is the general partner of GA ALN. General Atlantic, L.P., a Delaware limited partnership ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. GA LP is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee"). GAPCO Management GmbH, a German company ("GAPCO Management"), is the general partner of GAPCO KG. The Partnership Committee also controls GASC as well as the investment and voting decisions of GAPCO Management. There are six members of the Partnership Committee. Each of the members of the Partnership Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein.

SEC source: 0000950142-25-002442 · es250679024_4-alhc2.xml · nonDerivative · entry 1

General Atlantic (ALN HLTH), L.P. · CIK 0001853603 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 30,842,175

F1 · kind: The shares of Common Stock were sold by General Atlantic (ALN HLTH), L.P., a Delaware limited partnership ("GA ALN"), pursuant to an open market sale of 13,460,000 shares of Common Stock settled on September 12, 2025 at a net price per share of $16.01.

F2 · ownership.nature: Reflects (i) 30,533,323 shares of Common Stock held directly by GA ALN following the closing of the Transaction and (ii) 135,716 shares of Common Stock and 18,710 restricted stock units held by Nicholas Robbert Vorhoff and 135,716 shares of Common Stock and 18,710 restricted stock units held by David C. Hodgson, in each case for the benefit of General Atlantic Service Company, L.P. ("GASC"). The limited partners of GA ALN are the following investment funds (the "GA Funds"): General Atlantic Partners 95, L.P., a Delaware limited partnership ("GAP 95"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), GAP Coinvestments V, LLC, a Delaware limited liability company ("GAPCO V") and GAPCO GmbH & Co. KG, a German partnership ("GAPCO KG"). (Cont'd in FN3)

F3 · ownership.nature: (Cont'd from FN2) General Atlantic GenPar, L.P., a Delaware limited partnership ("GA GenPar"), is the general partner of GAP 95. General Atlantic (SPV) GP, LLC, a Delaware limited liability company ("GA SPV"), is the general partner of GA ALN. General Atlantic, L.P., a Delaware limited partnership ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. GA LP is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee"). GAPCO Management GmbH, a German company ("GAPCO Management"), is the general partner of GAPCO KG. The Partnership Committee also controls GASC as well as the investment and voting decisions of GAPCO Management. There are six members of the Partnership Committee. Each of the members of the Partnership Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein.

SEC source: 0001032563-25-000006 · wk-form4_1757549468.xml · nonDerivative · entry 2

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 343,592

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.74 to $17.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001032563-25-000006 · wk-form4_1757549468.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 352,403

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.74 to $16.735. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001850397-25-000008 · wk-form4_1757549260.xml · nonDerivative · entry 3

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,797,237

F4 · kind: Date of Rule 10b5-1 plan adoption: 05/22/2025

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.03 to $16.73. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001850397-25-000008 · wk-form4_1757549260.xml · nonDerivative · entry 2

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,904,460

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.74 to $17.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001850397-25-000008 · wk-form4_1757549260.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,935,344

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.74 to $16.735. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001222028-25-000007 · wk-form4_1757549039.xml · nonDerivative · entry 3

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,193,100

F4 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025

F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.03 to $16.73. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F6 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001222028-25-000007 · wk-form4_1757549039.xml · nonDerivative · entry 2

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,533,568

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.74 to $17.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001222028-25-000007 · wk-form4_1757549039.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,634,678

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.74 to $16.735. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001975024-25-000006 · wk-form4_1757549335.xml · nonDerivative · entry 2

Scavo Robert L. · CIK 0001975024 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 572,555

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.74 to $17.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001975024-25-000006 · wk-form4_1757549335.xml · nonDerivative · entry 1

Scavo Robert L. · CIK 0001975024 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 580,967

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.74 to $16.735. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001209523-25-000003 · wk-form4_1757549135.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,127,049

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/05/2025

SEC source: 0002006326-25-000003 · wk-form4_1756158093.xml · nonDerivative · entry 1

Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 192,043

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/11/2025

SEC source: 0001993255-25-000007 · wk-form4_1755899059.xml · nonDerivative · entry 1

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 447,367

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2025

SEC source: 0001850397-25-000003 · wk-form4_1755289719.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,012,899

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/25/2024

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.64 to $15.13. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001993255-25-000005 · wk-form4_1755289870.xml · nonDerivative · entry 1

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 472,167

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.00 to $15.09. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001222028-25-000003 · wk-form4_1755116531.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,373,100

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.42 to $14.80. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001993255-25-000003 · wk-form4_1755116645.xml · nonDerivative · entry 1

Kim Hyong · CIK 0001993255 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 490,767

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.42 to $14.61. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-037274 · wk-form4_1754087278.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 374,531

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/27/2024

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.00 to $16.01. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-037272 · wk-form4_1754086636.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,152,049

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/05/2025

SEC source: 0001628280-25-034974 · wk-form4_1752612100.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,042,899

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/25/2024

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.21 to $13.68. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-034810 · wk-form4_1752268473.xml · nonDerivative · entry 2

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,553,100

F3 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025

F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $13.28 to $13.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F5 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-25-031959 · wk-form4_1750203650.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,072,899

F1 · kind: Date of Rule 10b5-1 plan adoption: 11/24/2024

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.24 to $14.92. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-031961 · wk-form4_1750203769.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,733,100

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/12/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.23 to $14.92. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-25-031106 · wk-form4_1749764703.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,823,100

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/14/2024

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.61 to $15.58. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-25-031108 · wk-form4_1749764843.xml · nonDerivative · entry 2

Scavo Robert L. · CIK 0001975024 · Chief Information Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 602,090

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/11/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.10 to $15.51. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-031341 · wk-form4_1749846734.xml · nonDerivative · entry 1

Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 204,075

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/11/2025

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.00 to $15.45. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-031108 · wk-form4_1749764843.xml · nonDerivative · entry 1

Scavo Robert L. · CIK 0001975024 · Chief Information Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 642,953

F1 · kind: Date of Rule 10b5-1 plan adoption: 03/11/2025

SEC source: 0001628280-25-030008 · wk-form4_1749241063.xml · nonDerivative · entry 1

Head James M · CIK 0001842028 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,593

F1 · shares: Represents 81,593 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest in approximately equal installments on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company on the applicable vesting date.

SEC source: 0000950142-25-001447 · es250631276_4-alhc1.xml · nonDerivative · entry 1

GENERAL ATLANTIC, L.P. · CIK 0001017645 · Director · 10% owner

GENERAL ATLANTIC GENPAR, L.P. · CIK 0001467926 · Director · 10% owner

General Atlantic Partners 95, L.P. · CIK 0001606259 · Director · 10% owner

GAP COINVESTMENTS III, LLC · CIK 0001282203 · Director · 10% owner

GAP COINVESTMENTS IV, LLC · CIK 0001282372 · Director · 10% owner

GAP Coinvestments V, LLC · CIK 0001793941 · Director · 10% owner

GAPCO GMBH & CO KG · CIK 0001187388 · Director · 10% owner

GAPCO MANAGEMENT GMBH · CIK 0001187390 · Director · 10% owner

GAP Coinvestments CDA, L.P. · CIK 0001356474 · Director · 10% owner

General Atlantic (SPV) GP, LLC · CIK 0001793940 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 44,302,175

F1 · kind: The shares of Common Stock were sold by General Atlantic (ALN HLTH), L.P., a Delaware limited partnership ("GA ALN"), pursuant to an open market sale of 17,000,000 shares of Common Stock on May 19, 2025 at a net price per share of $15.28.

F2 · ownership.nature: Reflects (i) 43,993,323 shares of Common Stock held directly by GA ALN following the closing of the Transaction and (ii) 135,716 shares of Common Stock and 18,710 restricted stock units held by Nicholas Robbert Vorhoff and 135,716 shares of Common Stock and 18,710 restricted stock units held by David C. Hodgson, in each case for the benefit of General Atlantic Service Company, L.P. ("GASC"). The limited partners of GA ALN are the following investment funds (the "GA Funds"): General Atlantic Partners 95, L.P., a Delaware limited partnership ("GAP 95"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), GAP Coinvestments V, LLC, a Delaware limited liability company ("GAPCO V") and GAPCO GmbH & Co. KG, a German partnership ("GAPCO KG"). (Cont'd in FN3)

F3 · ownership.nature: (Cont'd from FN2) General Atlantic GenPar, L.P., a Delaware limited partnership ("GA GenPar"), is the general partner of GAP 95. General Atlantic (SPV) GP, LLC, a Delaware limited liability company ("GA SPV"), is the general partner of GA ALN. General Atlantic, L.P., a Delaware limited partnership ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. GA LP is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee"). GAPCO Management GmbH, a German company ("GAPCO Management"), is the general partner of GAPCO KG. The Partnership Committee also controls GASC as well as the investment and voting decisions of GAPCO Management. There are five members of the Partnership Committee. Each of the members of the Partnership Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein.

SEC source: 0000950142-25-001448 · es250631277_4-alhc2.xml · nonDerivative · entry 1

General Atlantic (ALN HLTH), L.P. · CIK 0001853603 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 44,302,175

F1 · kind: The shares of Common Stock were sold by General Atlantic (ALN HLTH), L.P., a Delaware limited partnership ("GA ALN"), pursuant to an open market sale of 17,000,000 shares of Common Stock on May 19, 2025 at a net price per share of $15.28.

F2 · ownership.nature: Reflects (i) 43,993,323 shares of Common Stock held directly by GA ALN following the closing of the Transaction and (ii) 135,716 shares of Common Stock and 18,710 restricted stock units held by Nicholas Robbert Vorhoff and 135,716 shares of Common Stock and 18,710 restricted stock units held by David C. Hodgson, in each case for the benefit of General Atlantic Service Company, L.P. ("GASC"). The limited partners of GA ALN are the following investment funds (the "GA Funds"): General Atlantic Partners 95, L.P., a Delaware limited partnership ("GAP 95"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), GAP Coinvestments V, LLC, a Delaware limited liability company ("GAPCO V") and GAPCO GmbH & Co. KG, a German partnership ("GAPCO KG"). (Cont'd in FN3)

F3 · ownership.nature: (Cont'd from FN2) General Atlantic GenPar, L.P., a Delaware limited partnership ("GA GenPar"), is the general partner of GAP 95. General Atlantic (SPV) GP, LLC, a Delaware limited liability company ("GA SPV"), is the general partner of GA ALN. General Atlantic, L.P., a Delaware limited partnership ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. GA LP is controlled by the Partnership Committee of GASC MGP, LLC (the "Partnership Committee"). GAPCO Management GmbH, a German company ("GAPCO Management"), is the general partner of GAPCO KG. The Partnership Committee also controls GASC as well as the investment and voting decisions of GAPCO Management. There are five members of the Partnership Committee. Each of the members of the Partnership Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein.

SEC source: 0001628280-25-025554 · wk-form4_1747256603.xml · nonDerivative · entry 2

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,102,899

F1 · kind: Date of adoption of Rule 10b5-1 plan: 11/25/2024

F3 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.09 to $15.17. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-025554 · wk-form4_1747256603.xml · nonDerivative · entry 1

Maroney Dawn Christine · CIK 0001850397 · President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,110,735

F1 · kind: Date of adoption of Rule 10b5-1 plan: 11/25/2024

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.09 to $15.08. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

SEC source: 0001628280-25-025552 · wk-form4_1747256478.xml · nonDerivative · entry 1

KAO JOHN E · CIK 0001222028 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · See Footnote

Disclosed balance after: 1,913,100

F1 · kind: Date of adoption of Rule 10b5-1 plan: 03/14/2024

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $14.70 to $15.15. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

F3 · ownership.nature: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

SEC source: 0001628280-25-024371 · wk-form4_1746825100.xml · nonDerivative · entry 1

McCarthy Margaret M · CIK 0001485980 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,168

F1 · shares: Represents 1,290 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on March 13, 2026, unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares until separation of service as a director (or, if earlier, until a change of control of the Company).

SEC source: 0001628280-25-024357 · wk-form4_1746824839.xml · nonDerivative · entry 1

KONOWIECKI JOSEPH S · CIK 0001209523 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,177,049

F1 · shares: Represents 12,903 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on March 13, 2026, unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares for three years (or, if earlier, upon separation of service or a change of control of the Company).

SEC source: 0001628280-25-021871 · wk-form4_1746217763.xml · nonDerivative · entry 1

JOYCE CHRISTOPHER J · CIK 0001032563 · Chief Legal and Admin. Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 390,022

F1 · kind: Date of adoption of Rule 10b5-1 plan: 11/27/2024

F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.59 to $17.37. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.